Watchlist Price Alert

Innoviva Inc. (INVA)

NASDAQ: INVA · Real-Time Price · USD

19.55

0.06 (0.31%)

At close: May 30, 2025, 3:59 PM

19.52

-0.18%

After-hours: May 30, 2025, 04:58 PM EDT

0.31% (1D)

Bid	18.88
Market Cap	1.23B
Revenue (ttm)	373.3M
Net Income (ttm)	-59.72M
EPS (ttm)	-0.95
PE Ratio (ttm)	-20.58
Forward PE	7.26
Analyst	Buy

Ask	19.52
Volume	543,089
Avg. Volume (20D)	896,480
Open	19.54
Previous Close	19.49
Day's Range	19.40 - 19.66
52-Week Range	15.37 - 21.28
Beta	0.36

About INVA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol INVA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for INVA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

News

1 week ago · businesswire.com

ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections

WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced the United States commercial availability of ZEVTERA® (ceftobipro...

2 months ago · 247wallst.com

Billionaire Healthcare Investor Alex Denner's Hedge Fund Has 75% of Its Assets in These 3 Stocks

If you work in the biotech industry, you might know the name Alex Denner.

2 months ago · businesswire.com

Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference

BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious ...